The clearance expands Galvanize’s pulsed electric field portfolio for soft tissue ablation, supporting broader lesion treatment and limited US commercial release. ...
The submission moves PorTal Access closer to a planned mid-summer launch, positioning Flexi-Port as a differentiated vascular access solution for oncology and long-term infusion therapy. ...
Over 1,000 investment and business matching meetings, MoUs to support healthcare enterprises to go global ...
The company will present Proliv Rx, its FDA-approved physician-directed neuromodulation therapy for adults with major depressive disorder who have not responded adequately to antidepressant medication. ...
The FDA marketing authorisation establishes a new Class II device category for Aurie’s automated reusable no-touch intermittent urinary catheter system, with launch planned in Veterans Health Administration spinal cord injury hospitals later this year. ...
The FDA 510(k) clearance advances Biozen’s BP1000, a handheld fingertip device designed to deliver clinically validated spot blood pressure measurements without an arm cuff or per-user calibration. ...
The event highlighted healthcare AI’s shift from experimentation to real-world deployment, with discussions on accountability, governance, workforce readiness and exhibitor solutions including Heidi and AITRICS-VC....
The NMPA designation advances NHWD-870 HCI, an oral BET inhibitor for advanced thoracic NUT carcinoma, following Phase II data showing anti-tumour activity and survival benefit in a rare, aggressive cancer with limited treatment options. ...
The new x-ray irradiator uses tomosynthesis-based 3D imaging and faster dose delivery to make targeted preclinical radiotherapy studies more accessible to research laboratories. ...
The new patent expands protection around Spinal Resources’ variable-stiffness spinal fixation platform, strengthening its intellectual property position across the rod, implant system, and AI-enabled patient-specific design methodology. ...
